Hester Biosciences Ltd

HESTERBIO
Health CareBiotechnology
SmallcapWith a market cap of ₹2,077 cr, stock is ranked 727
Moderate RiskStock is 2.15x as volatile as Nifty
2,388.0553.90 (-2.21%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹2,077 cr, stock is ranked 727
Moderate RiskStock is 2.15x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
60.35
PB RatioPB Ratio
8.80
Dividend YieldDiv. Yield
0.41%
Sector PESector PE
33.47
Sector PBSector PB
4.80
Sector Div YldSctr Div Yld
0.85%

Forecast & RatingsDetailed Forecast 

0%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Hester Biosciences Limited is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include Poultry Division and Large Animal Division.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021138.49185.28189.64219.0125.6141.5729.1834.42
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 14, 2022

Hester Biosciences Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Hester Biosciences Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Disclosure under SEBI Takeover Regulations 
Announced OnApr 9, 2022

Promoter/Promoter Group of Hester Biosciences Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 | Download

Promoter/Promoter Group of Hester Biosciences Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 | Download

Cash Dividend 
Ex. DateAug 5, 2021

Final • Div/Share: ₹ 10

See all events